Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing

Qianwen Chen,1,2,* Wenjuan Zhang,2,3,* Lingfeng Zha2 1Department of Pediatric Cardiology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430070, People’s Republic of China; 2Department of Car...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen Q, Zhang W, Zha L
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Online Access:https://www.dovepress.com/molecular-genetic-analysis-of-a-dmd-frameshift-mutation-in-a-boy-with--peer-reviewed-fulltext-article-PGPM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850157356414926848
author Chen Q
Zhang W
Zha L
author_facet Chen Q
Zhang W
Zha L
author_sort Chen Q
collection DOAJ
description Qianwen Chen,1,2,* Wenjuan Zhang,2,3,* Lingfeng Zha2 1Department of Pediatric Cardiology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430070, People’s Republic of China; 2Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 3Department of Geriatrics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lingfeng Zha, Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China, Email zhalf@hust.edu.cnAbstract: Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disease that is characterized by progressive proximal muscle weakness and pseudohypertrophy. Currently, genetic diagnosis of DMD relies largely on multiplex ligation-dependent probe analysis (MLPA) and Sanger sequencing to identify pathogenic mutations. This study aimed to confirm the genetic etiology of a boy presenting with clinical manifestations that are highly indicative of DMD. A 14-year-old boy with heart failure and extreme muscle weakness along with his family members was recruited for this study. DNA from each participant was isolated from peripheral blood samples. We used MLPA to detect the deletion or duplication mutations of the DMD gene and Sanger sequencing to verify the missing region of the exon in the proband. Furthermore, the functional role of the mutation was assessed using bioinformatics. We found that the proband carried a small deletion in the DMD gene (c.6808_6811delTTAA). The deletion of those four nucleotides resulted in a frameshift mutation and a premature nonsense codon, which resulted in a truncated dystrophin that lost its most critical function and underwent post-transcriptional degradation. Our study demonstrated that MLPA, in combination with Sanger sequencing, is a reliable and practical approach for the genetic diagnosis of DMD, which is a significant step towards developing personalized therapy.Keywords: DMD, MLPA, Sanger, exon skipping, personalized therapy
format Article
id doaj-art-3f7d8975a62046baafe5f60165d309ae
institution OA Journals
issn 1178-7066
language English
publishDate 2025-06-01
publisher Dove Medical Press
record_format Article
series Pharmacogenomics and Personalized Medicine
spelling doaj-art-3f7d8975a62046baafe5f60165d309ae2025-08-20T02:24:13ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662025-06-01Volume 18Issue 1153162104002Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger SequencingChen Q0Zhang W1Zha L2Department of Pediatric CardiologyDepartment of GeriatricsDepartment of CardiologyQianwen Chen,1,2,* Wenjuan Zhang,2,3,* Lingfeng Zha2 1Department of Pediatric Cardiology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430070, People’s Republic of China; 2Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China; 3Department of Geriatrics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Lingfeng Zha, Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China, Email zhalf@hust.edu.cnAbstract: Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disease that is characterized by progressive proximal muscle weakness and pseudohypertrophy. Currently, genetic diagnosis of DMD relies largely on multiplex ligation-dependent probe analysis (MLPA) and Sanger sequencing to identify pathogenic mutations. This study aimed to confirm the genetic etiology of a boy presenting with clinical manifestations that are highly indicative of DMD. A 14-year-old boy with heart failure and extreme muscle weakness along with his family members was recruited for this study. DNA from each participant was isolated from peripheral blood samples. We used MLPA to detect the deletion or duplication mutations of the DMD gene and Sanger sequencing to verify the missing region of the exon in the proband. Furthermore, the functional role of the mutation was assessed using bioinformatics. We found that the proband carried a small deletion in the DMD gene (c.6808_6811delTTAA). The deletion of those four nucleotides resulted in a frameshift mutation and a premature nonsense codon, which resulted in a truncated dystrophin that lost its most critical function and underwent post-transcriptional degradation. Our study demonstrated that MLPA, in combination with Sanger sequencing, is a reliable and practical approach for the genetic diagnosis of DMD, which is a significant step towards developing personalized therapy.Keywords: DMD, MLPA, Sanger, exon skipping, personalized therapyhttps://www.dovepress.com/molecular-genetic-analysis-of-a-dmd-frameshift-mutation-in-a-boy-with--peer-reviewed-fulltext-article-PGPMDMDMLPASangerexon skippingpersonalized therapy
spellingShingle Chen Q
Zhang W
Zha L
Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
Pharmacogenomics and Personalized Medicine
DMD
MLPA
Sanger
exon skipping
personalized therapy
title Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
title_full Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
title_fullStr Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
title_full_unstemmed Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
title_short Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
title_sort molecular genetic analysis of a dmd frameshift mutation in a boy with duchenne muscular dystrophy by mlpa and sanger sequencing
topic DMD
MLPA
Sanger
exon skipping
personalized therapy
url https://www.dovepress.com/molecular-genetic-analysis-of-a-dmd-frameshift-mutation-in-a-boy-with--peer-reviewed-fulltext-article-PGPM
work_keys_str_mv AT chenq moleculargeneticanalysisofadmdframeshiftmutationinaboywithduchennemusculardystrophybymlpaandsangersequencing
AT zhangw moleculargeneticanalysisofadmdframeshiftmutationinaboywithduchennemusculardystrophybymlpaandsangersequencing
AT zhal moleculargeneticanalysisofadmdframeshiftmutationinaboywithduchennemusculardystrophybymlpaandsangersequencing